These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 30281973)

  • 1. Clearance in Drug Design.
    Smith DA; Beaumont K; Maurer TS; Di L
    J Med Chem; 2019 Mar; 62(5):2245-2255. PubMed ID: 30281973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predicting Clearance Mechanism in Drug Discovery: Extended Clearance Classification System (ECCS).
    Varma MV; Steyn SJ; Allerton C; El-Kattan AF
    Pharm Res; 2015 Dec; 32(12):3785-802. PubMed ID: 26155985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Key to Opening Kidney for In Vitro-In Vivo Extrapolation Entrance in Health and Disease: Part I: In Vitro Systems and Physiological Data.
    Scotcher D; Jones C; Posada M; Rostami-Hodjegan A; Galetin A
    AAPS J; 2016 Sep; 18(5):1067-1081. PubMed ID: 27365096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. When Does the Rate-Determining Step in the Hepatic Clearance of a Drug Switch from Sinusoidal Uptake to All Hepatobiliary Clearances? Implications for Predicting Drug-Drug Interactions.
    Patilea-Vrana GI; Unadkat JD
    Drug Metab Dispos; 2018 Nov; 46(11):1487-1496. PubMed ID: 30115647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of human pharmacokinetics - renal metabolic and excretion clearance.
    Fagerholm U
    J Pharm Pharmacol; 2007 Nov; 59(11):1463-71. PubMed ID: 17976256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification and quantitation of enzyme and transporter contributions to hepatic clearance for the assessment of potential drug-drug interactions.
    Kimoto E; Obach RS; Varma MVS
    Drug Metab Pharmacokinet; 2020 Feb; 35(1):18-29. PubMed ID: 31952912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transporters as a determinant of drug clearance and tissue distribution.
    Shitara Y; Horie T; Sugiyama Y
    Eur J Pharm Sci; 2006 Apr; 27(5):425-46. PubMed ID: 16488580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of hepatic uptake transporters on pharmacokinetics and drug-drug interactions: use of assays and models for decision making in the pharmaceutical industry.
    Soars MG; Webborn PJ; Riley RJ
    Mol Pharm; 2009; 6(6):1662-77. PubMed ID: 19402709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetic modeling of the hepatobiliary transport mediated by cooperation of uptake and efflux transporters.
    Kusuhara H; Sugiyama Y
    Drug Metab Rev; 2010 Aug; 42(3):539-50. PubMed ID: 20175646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transporter-Enzyme Interplay: Deconvoluting Effects of Hepatic Transporters and Enzymes on Drug Disposition Using Static and Dynamic Mechanistic Models.
    Varma MV; El-Kattan AF
    J Clin Pharmacol; 2016 Jul; 56 Suppl 7():S99-S109. PubMed ID: 27385183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Criticism of pharmacokinetic clearance concepts.
    Keller F; Schoole J
    Int J Clin Pharmacol Ther Toxicol; 1983 Nov; 21(11):563-8. PubMed ID: 6654532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Importance of Hepatic Transporters in Clinical Disposition of Drugs and Their Metabolites.
    Patel M; Taskar KS; Zamek-Gliszczynski MJ
    J Clin Pharmacol; 2016 Jul; 56 Suppl 7():S23-39. PubMed ID: 27385177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The kidney--the body's playground for drugs: an overview of renal drug handling with selected clinical correlates.
    Perri D; Ito S; Rowsell V; Shear NH
    Can J Clin Pharmacol; 2003; 10(1):17-23. PubMed ID: 12687033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Transporter-mediated drug-drug interaction in renal and hepatic elimination processes].
    Nagai J
    Nihon Yakurigaku Zasshi; 2010 Jan; 135(1):34-7. PubMed ID: 20075569
    [No Abstract]   [Full Text] [Related]  

  • 15. Key to Opening Kidney for In Vitro-In Vivo Extrapolation Entrance in Health and Disease: Part II: Mechanistic Models and In Vitro-In Vivo Extrapolation.
    Scotcher D; Jones C; Posada M; Galetin A; Rostami-Hodjegan A
    AAPS J; 2016 Sep; 18(5):1082-1094. PubMed ID: 27506526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predicting human hepatic clearance from in vitro drug metabolism and transport data: a scientific and pharmaceutical perspective for assessing drug-drug interactions.
    Camenisch G; Umehara K
    Biopharm Drug Dispos; 2012 May; 33(4):179-94. PubMed ID: 22407504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transport vs. Metabolism: What Determines the Pharmacokinetics and Pharmacodynamics of Drugs? Insights From the Extended Clearance Model.
    Patilea-Vrana G; Unadkat JD
    Clin Pharmacol Ther; 2016 Nov; 100(5):413-418. PubMed ID: 27448198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of the hepatic and renal clearance of transporter substrates in rats using in vitro uptake experiments.
    Watanabe T; Maeda K; Kondo T; Nakayama H; Horita S; Kusuhara H; Sugiyama Y
    Drug Metab Dispos; 2009 Jul; 37(7):1471-9. PubMed ID: 19364828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of intrinsic clearance for prediction of human hepatic clearance.
    Chao P; Uss AS; Cheng KC
    Expert Opin Drug Metab Toxicol; 2010 Feb; 6(2):189-98. PubMed ID: 20073997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predicting the Human Hepatic Clearance of Acidic and Zwitterionic Drugs.
    Tess DA; Eng H; Kalgutkar AS; Litchfield J; Edmonds DJ; Griffith DA; Varma MVS
    J Med Chem; 2020 Oct; 63(20):11831-11844. PubMed ID: 32985885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.